Lobeglitazone
Lobeglitazone is an oral antidiabetic medication used to improve blood glucose control in adults with type 2 diabetes mellitus, generally alongside diet and exercise. It belongs to the thiazolidinedione class and works by activating peroxisome proliferator-activated receptor gamma (PPAR-γ), improving insulin sensitivity in muscle and adipose tissue. It is available as oral tablets, with approved strengths and indications varying by market. Possible side effects include weight gain, oedema, headache, and upper respiratory tract infections. Important precautions include the risk of fluid retention, worsening heart failure, and bone fractures; it should be used cautiously in patients with cardiac or liver conditions. Lobeglitazone should be prescribed under medical supervision, with regular monitoring of blood glucose, liver function when appropriate, and signs of fluid retention.
Lobeglitazone was historically used as a respiratory medicine for the symptomatic management of certain respiratory conditions. Its former uses included:
is okay
The import of medicines into India is regulated by the Central Drugs Standard Control Organisation (CDSCO) under the Drugs and Cosmetics Act, 1940, and the Drugs and Cosmetics Rules, 1945. The regulatory requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished formulation, or an unapproved medicine intended for an individual patient's treatment.
Primeera Healthcare Private Limited can provide import coordination and pharmaceutical documentation assistance for Lobeglitazone, subject to confirmation of its current regulatory status and eligibility for import into India.
The export of Lobeglitazone from India is subject to applicable requirements under the Drugs and Cosmetics Act, 1940, the Drugs and Cosmetics Rules, 1945, and relevant export, customs, and destination-country regulations. Documentation requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished pharmaceutical formulation, or a medicine intended for a specific market. Export eligibility and destination-country requirements must be verified before shipment.
Primeera Healthcare Private Limited can provide pharmaceutical export documentation assistance, regulatory coordination, and shipping support for Lobeglitazone, subject to confirmation of its export eligibility under applicable Indian regulations and the import requirements of the destination country.
If you have any questions or need any help, contact our Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
All Trademarks and Brands that appear on the website belong to their respective owners. Primeera Healthcare does not lay any claim on them; we only provide information.
